Word

BRYLEOS

Status

Pending

Status Code

688

Status Date

Tuesday, January 2, 2024

Serial Number

97715158

Mark Type

4000

Filing Date

Tuesday, December 13, 2022

Published for Opposition

Tuesday, November 7, 2023

Trademark Owner History

BioNADrx Holdings, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for humans and animals for the prevention and treatment of neurologic, cardiovascular, dermatologic, inflammatory, immunologic, neuromuscular, reproductive, pancreatic, metabolic, hepatic, inflammatory, psychiatric, and orthopedic diseases, disorders, and conditions; Pharmaceutical preparations for humans and animals for the prevention and treatment of substance use disorder and substance withdrawal; Pharmaceutical preparations for humans and animals for use in treating and managing diseases, disorders, and conditions relating to aging; Therapeutic preparations for humans and animals, namely, therapeutic pharmaceutical preparations for the treatment and prevention of intracellular NAD depletion; Therapeutic preparations for humans and animals, namely, therapeutic pharmaceutical preparations for replenishing coenzyme depletion; Therapeutic agents for humans and animals for regulation of gene expression in aging and metabolic disease, nutrient sensing, and inflammasome suppression

1 Chemicals for use in agriculture, horticulture, and botany, except fungicides, herbicides, insecticides, and parasiticides; Chemical preparations for use in agriculture, horticulture, and botany, namely, chemical preparations for managing growth, health, and sustainability of plants except fungicides, herbicides, insecticides, and parasiticides; Substances for regulating growth in plants; Chemical preparations to prevent and treat diseases affecting rooted plants

42 Research and development in the fields of human and veterinary pharmaceuticals, intracellular NAD depletion, aging, and aging-related diseases, disorders, and conditions for humans and animals; Providing medical scientific information in the fields of human and veterinary pharmaceuticals, intracellular NAD depletion, aging, and aging-related diseases, disorders, and conditions for humans and animals

Trademark Events

Jan 2, 2024

Noa E-Mailed - Sou Required From Applicant

Nov 7, 2023

Official Gazette Publication Confirmation E-Mailed

Nov 7, 2023

Published For Opposition

Oct 18, 2023

Notification Of Notice Of Publication E-Mailed

Oct 2, 2023

Approved For Pub - Principal Register

Oct 2, 2023

Examiner's Amendment Entered

Oct 2, 2023

Notification Of Examiners Amendment E-Mailed

Oct 2, 2023

Examiners Amendment E-Mailed

Oct 2, 2023

Examiners Amendment -Written

Sep 27, 2023

Teas/Email Correspondence Entered

Sep 26, 2023

Correspondence Received In Law Office

Sep 26, 2023

Teas Response To Office Action Received

Sep 18, 2023

Notification Of Non-Final Action E-Mailed

Sep 18, 2023

Non-Final Action E-Mailed

Sep 18, 2023

Non-Final Action Written

Sep 18, 2023

Assigned To Examiner

Jan 10, 2023

New Application Office Supplied Data Entered

Dec 16, 2022

New Application Entered